Clinical Trial Update: Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated topical estradiol and genistein for postmenopausal facial skin atrophy and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Atrophy

Drugs mentioned

• Estradiol (topical) (estradiol)
• Genistein (topical) (genistein)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Atrophy | Phase 2 | Status: COMPLETED